Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Setrusumab by Ultragenyx Pharmaceutical for Osteogenesis Imperfecta: Likelihood of Approval
Setrusumab is under clinical development by Ultragenyx Pharmaceutical and currently in Phase III for Osteogenesis Imperfecta. According to GlobalData, Phase...